Maternal Blood Pressure Rise During Pregnancy and Offspring Obesity Risk at 4 to 7 Years Old: The Jiaxing Birth Cohort. by Zheng, Jusheng et al.
C L I N I C A L R E S E A R C H A R T I C L E
Maternal Blood Pressure Rise During Pregnancy
and Offspring Obesity Risk at 4 to 7 Years Old:
The Jiaxing Birth Cohort
Ju-Sheng Zheng,1,2 Huijuan Liu,3 Ken K. Ong,2,4 Tao Huang,5 Yuhong Guan,3
Yuan Huang,6 Bo Yang,1 Fenglei Wang,7 and Duo Li1,7
1Institute of Nutrition & Health, Qingdao University, Qingdao 26071, China; 2Medical Research Council
Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ,
United Kingdom; 3Jiaxing Maternity and Child Health Care Hospital, Jiaxing 314051, China; 4Department of
Paediatrics, University of Cambridge, Cambridge CB2 0QQ, United Kingdom; 5Saw Swee Hock School of
Public Health, National University of Singapore, Singapore 117549; 6EPSRC Centre for Mathematical and
Statistical Analysis of Multimodal Clinical Imaging, University of Cambridge, Cambridge CB3 0WB,
United Kingdom; and 7Department of Food Science and Nutrition, Zhejiang University, Hangzhou
310058, China
Context: Maternal hypertensive disorders during pregnancy are suggested to affect obesity risk in
offspring. However, little is known about the prospective association of rise in maternal blood
pressure within normal range during pregnancy with this risk for obesity.
Objective: To clarify the associations of diastolic and systolic blood pressure during pregnancy
among normotensive women with the risk for obesity in offspring.
Design: Prospective cohort study.
Setting: Southeast China.
Participants:Up to 2013, a total of 88,406mother-child pairs with anthropometric measurements of
offspring age 4 to 7 years were included in the present analysis.
Main Outcome Measures: Overweight/obesity risk in offspring.
Results:Amongnormotensivewomen, second- and third-trimester diastolic and systolic bloodpressures
werepositively associatedwith risk foroverweight/obesity inoffspring: odds ratiosper10–mmHghigher
second- and third-trimester diastolic bloodpressurewere 1.05 [95%confidence interval (CI), 1.01 to 1.09]
and 1.05 (95% CI, 1.02 to 1.10), respectively, and for systolic blood pressure were 1.08 (95% CI, 1.05 to
1.11) and 1.06 (95% CI, 1.03 to 1.09). Each 10–mm Hg greater rise in blood pressure between first and
third trimesterswasassociatedwithahigher risk foroffspringoverweight/obesity: diastolic, 1.06 (95%CI,
1.01 to 1.10); systolic, 1.05 (95% CI, 1.02 to 1.07). Among all women (combining normotensive and
hypertensive women), maternal hypertension in the second and third trimesters was associated with
49% and 14% higher risks for overweight/obesity in offspring, respectively.
Conclusions: These results suggest that rise in maternal blood pressure during pregnancy and
hypertension during pregnancy, independent of maternal body size before pregnancy, are risk
factors for offspring childhood obesity. (J Clin Endocrinol Metab 102: 4315–4322, 2017)
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The prevalence of childhood obesity has increasedglobally during the past 2 decades, especially among
developing countries, such as China. In 2010, the age-
adjusted prevalence of obesity and overweight/obesity
was 8.1% and 19.2%, respectively (by percentage
weight-for-height standards), among Chinese children
age 7 to 18 years in the Chinese National Surveys on
Students’ Constitution and Health (1). There is strong
evidence that childhood obesity is associated with many
related health problems in adulthood, including obesity,
type 2 diabetes, and cardiovascular disease (2). In ad-
dition, childhood obesity leads to many childhood and
adolescent comorbidities, such as hypertension, early
puberty, menstrual irregularities, polycystic ovary syn-
drome, and asthma (3). To curb the epidemic of the
childhood obesity, it is crucial to identify its potential risk
factors as potential targets for prevention. Thus far, a
variety of risk factors for childhood obesity have been
identified, including parental obesity, birthweight, rapid
weight gain during infancy, breastfeeding, short sleeping
duration of the children, and genetic variations (3, 4).
However, little is known about the role of maternal
pregnancy blood pressure (BP) in the development of
offspring overweight and obesity in childhood.
Hypertensive disorders during pregnancy (including
preeclampsia and gestational hypertension) are associ-
ated with impaired fetal growth and higher risk for
multiple adverse birth outcomes (5, 6) and are weakly
associated with higher offspring body mass index (BMI)
or obesity risk in later life (7, 8). Although a few studies
have reported the association of pregnancy BP with ad-
verse birth outcomes (5, 9–11), to the best of our
knowledge no studies have examined the prospective
association of maternal BP in a general population of
pregnant women with risk for obesity in offspring. In
addition, little is known about the association of change
in BP during pregnancy with this risk. Because hyper-
tensive disorders of pregnancy affect only ,10% of
pregnancies (12), investigation of the influence of BP
during pregnancy on the risk for obesity in offspring
among most pregnant women without hypertensive
disorders is potentially of greater impact. Given the in-
creasing public health concerns about childhood obesity,
it is of interest to examine whether maternal pregnancy
BP is an independent risk factor for offspring obesity. If
established, it may further our understanding of the
etiology of childhood obesity and inform relevant pre-
vention strategies.
Therefore, the primary aim of the current study was to
investigate the association between repeated measures of
maternal BP during pregnancy (in the first, second, and
third trimesters) with risk for offspring overweight/obesity
at preschool ages among normotensive women in the
Jiaxing Birth Cohort, China.
Participants and Methods
Study design and participants
The Jiaxing Birth Cohort (JBC) (1999 to 2013) was initiated
in 1999 based on an existing routine health monitoring system
in the Jiaxing area (a middle-income area in southeast China),
involving .0.3 million live mother-child pairs with extensive
follow-up information of the children up to age 6 to 7 years
before they started school (13).Women living at one of the seven
divisions/counties in the Jiaxing area came to register at local
clinics before pregnancy or at any stage of pregnancy. There-
after, participants came to visit the local clinics regularly until
the birth (16 to 28 gestational weeks: once every 4 weeks; 29 to
36 gestational weeks: once every 2 weeks; .36 gestational
weeks: once per week). Up to 2013, a total of 338,413 live
mother-child pairs were enrolled in the JBC study. For partic-
ipants who registered in the JBC study during pregnancy, their
prepregnancy anthropometric measurements were retrieved by
linking to a premarriage health check database held by the
Jiaxing Maternity and Child Health Care Hospital.
Children enrolled in the JBC study visited (with their parents)
the local clinics for health checks and anthropometric mea-
surements at ages 1 to 2months, 3 months, 6months, 9months,
and 12 months during infancy. In the following stage, children
visited the local clinics every 6 months (18, 24, 30, and
36 months) until age 36 months. Thereafter, children were
asked to visit the clinics once per year before they started school
(age 6 to 7 years).
Between 1999 and 2006, a total of 134,680 mother-child
(singleton) pairs were enrolled in the JBC study. Mother-child
pairs were excluded if they had extreme offspring birthweight
(,1500 g or.5000 g; n = 85) or preterm birth (,37 gestational
weeks; n = 4425), or no maternal BP record at any of the first,
second, or third trimesters (n = 426). Therefore, at baseline,
129,744 mother-child pairs were included in the current study.
Up to 2013, 89,185 children had follow-up information be-
tween ages 4 to 7 years (68.7% follow-up rate). For children
with multiple follow-ups between 4 and 7 years of age, the later
follow-up visit data were used to maximize the follow-up du-
ration. Children were excluded if they had any missing data on
anthropometric measurements (height or weight) at the follow-
up visit at ages 4 to 7 years (n = 779). Finally, 88,406 mother-
child pairs were included in the statistical analyses. The study
protocol was approved by the ethics committee of the College of
Biosystem Engineering & Food Science at Zhejiang University
in China. All participants provided oral informed consent.
Measurement of maternal BP and other
key variables
At each clinic visit, seated maternal BP was measured by
manual BPmonitors in the right arm on a single occasion after 5
to 10minutes of resting. At each of the three trimesters,maternal
pregnancy hypertension was defined as diastolic BP (DBP)
$90mmHg and/or systolic blood pressure (SBP)$140mmHg.
Because we could not separate different hypertensive disorders
of pregnancy, such as gestational hypertension or preeclampsia
(14), this definition (maternal pregnancy hypertension) represents
a combination of hypertensive disorders of pregnancy. BP
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measurements at the first health check (0 to 12 gestational
weeks) were considered as first-trimester BP. BPmeasurements
at a later health check between 13 and 28 gestational weeks were
considered as second-trimester BP. BP measurements at a health
check around 37 gestational weeks ($29 gestational weeks) was
considered as third-trimester BP.
At the first health check/recruitment of the participants,
maternal demographic characteristics were collected by inter-
view. Maternal anthropometric measurements (weight, height)
were taken on site by trained nurses. Maternal BMI was based
on prepregnancy (n = 43,831) or first-trimester measurements
(n = 36,491).
Offspring anthropometric assessment
Body weight and height of the children were measured by
trained nurses to the nearest 0.1 kg and 0.1 cm, respectively, at
each o follow-up clinic visit. Childhood overweight and obesity
were defined according to the international BMI cutoff points
by age and sex, as established by the International Obesity Task
Force (15).
Statistical analyses
All statistical analyses were performed using Stata software,
version 14 (Stata Corp., College Station, TX). Initially, logistic
regression was used to examine the odds ratio (OR) and 95%
confidence interval (CI) of offspring overweight/obesity per
10–mm Hg higher maternal DBP and SBP at first, second, and
third trimesters among normotensive women in three statistical
models: model 1, crude model without adjustment; model 2,
adjusted for maternal age (continuous), menarcheal age
(,14 years, 14 to 15 years, .15 years), education level (less
than high school, high school, more than high school), occu-
pation (farm work/house work, routine job, others), parity
(primiparous ormultiparous), offspring sex and offspring age at
examination (continuous); and model 3, model 2 plus maternal
BMI (continuous) and maternal height (continuous). We in-
cluded maternal BMI and height in model 3 to examine the
influence of maternal body size on the results in addition to
other covariates. Sensitivity analyses were conducted under
model 3 by adopting further potential confounders or inclusion
criteria: model 3a used additional covariates: maternal baseline
self-reported smoking and drinking status, and family history of
hypertension; model 3b included only women with prepreg-
nancy BMI data; and model 3c included all women with and
without hypertensive disorders.
Consequently, we examined (based on model 3) the fol-
lowing: (1) the association between change in BP (per 10–mm
Hg rise) during pregnancy with childhood overweight/obesity
risk among normotensive women and among all women,
adjusting for potential confounders; (2) the association between
maternal hypertension during pregnancy at each of the three
trimesters with risk for offspring overweight/obesity, adjusting
for potential confounders; and (3) fetal growth as a potential
mediator, for which we explored the association of maternal BP
(per 10–mm Hg increase) with offspring birthweight (contin-
uous) among normotensive women, and the difference in
birthweight between hypertensive and normotensive women.
To explore potential nonlinear relationships, we examined
the association (based on model 3) of maternal DBP and
SBP at each trimester with overweight/obesity risk, or off-
spring birthweight, using restricted cubic spline models [four
knots, according to Harrell’s recommendation (16)] among all
participants, including both hypertensive and normotensive
women. Four knots offer an adequate fit of the model and are a
good compromise between flexibility and loss of precision
caused by overfitting (16). There was no substantial difference
in the shape or nonlinear association when we selected three or
five knots.
Interaction between different pregnancy BP and different
maternal/infant characteristics (maternal age, BMI, menarcheal
age, and offspring sex) on risk for offspring overweight/obesity
was examined by adding relevant interaction terms to model 3.
We further examined potential meditation by birthweight, and
the proportion (% of total effect) mediated by birthweight using
the method proposed by Kenny (17). The binary_mediation
command in Stata was used to estimate the mediation effect
for our dichotomous outcome (overweight/obesity compared
with normal weight), and bias-corrected 95% CI was cal-
culated via bootstrapping with 500 replications (18). A two-
tailed P value, 0.05 was considered to indicate a statistically
significant difference.
Results
Population characteristics
The mean maternal age at birth of offspring was
25 years [standard deviation (SD), 3.7] andmeanmaternal
BMI was 20.5 kg/m2 (SD, 2.6). Mean maternal DBP in-
creased from 68.4 to 69.1 to 75.3 mm Hg in the first,
second, and third trimesters, respectively; similarly, SBP
increased from 105.9 to 108.7 to 115.2 mm Hg (Sup-
plemental Fig. 1). Mean gestational age at BP measure-
ment in the first, second, and third trimesters was
9.3 weeks (SD, 2.8), 26.4 weeks (SD, 1.8), and 38.7 weeks
(SD, 1.1), respectively. Among the children who were
followed up at age 4 to 7 years [mean age, 5.9 years (SD,
0.7)], 9.1%were overweight (6.6%) or obese (2.5%). The
proportion of children who were overweight/obese was
higher amongmothers who had younger age, higher BMI,
earlier menarcheal age, higher education levels, a routine
job, a first pregnancy, or caesarean delivery and in male
offspring (Table 1).
Maternal BP during pregnancy and offspring
overweight/obesity at childhood
Among normotensive women, apparent positive
associations between first-trimester BP and risk for
overweight/obesity in offspring were attenuated on ad-
justment for mother’s BMI and height (model 3). By
contrast, second- and third-trimester maternal DBP and
SBP were positively associated with risk for offspring
overweight/obesity: third-trimester DBP: OR per 10–mm
Hg increase, 1.05 (95% CI, 1.01 to 1.10); third-trimester
SBP: OR, 1.06 (95%CI, 1.03 to 1.09) in adjusted models
(model 3) (Fig. 1, Table 2). Similarly, maternal hyper-
tension in first trimester was not associated with offspring
risk for overweight/obesity, whereas hypertension in the
second (OR, 1.49; 95% CI, 1.18 to 1.89) and third (OR,
doi: 10.1210/jc.2017-01500 https://academic.oup.com/jcem 4317
Downloaded from https://academic.oup.com/jcem/article-abstract/102/11/4315/4259054
by University of Cambridge user
on 07 February 2018
1.14; 95% CI, 1.05 to 1.25) trimesters was associated
with higher risk for offspring overweight/obesity (Fig. 2).
Across both normotensive and hypertensive women, the
associations betweenmaternal BP and offspring overweight/
obesity risk appeared to be largely linear or J-shaped
(Supplemental Fig. 2). In sensitivity analyses, excluding
women without prepregnancy BMI slightly attenuated the
association only with third-trimester DBP (Supplemental
Table 1). No interaction was observed between DBP and
SBP with any maternal characteristic.
Changes in DBP and SBP from the first to the
third trimester among normotensive women were posi-
tively associated with risk for offspring overweight/
obesity: DBP: OR per 10– mm Hg rise: 1.06 (95%
CI, 1.02 to 1.10); SBP: OR, 1.05 (95% CI, 1.02 to
1.07) (Fig. 3). Across adjacent trimesters, BP changes
Table 1. Maternal and Offspring Characteristics by Offspring Adiposity Status at Age 4 to 7 Years in the
JBC (n = 88,450)
Characteristic Participants (n)
Offspring Without
Overweight/Obesity (n = 80,366)
Offspring With
Overweight/Obesity (n = 8084)
Maternal age
#25 y 54,427 90.7 9.3
26–30 y 23,146 90.5 9.5
31–35 y 9987 92.3 7.7
$36 y 857 92.0 8.0
Maternal BMI
,18.5 kg/m2 16,362 94.7 5.3
18.5–24.9 kg/m2 60,057 90.5 9.5
25–29.9 kg/m2 3421 81.4 18.6
$30 kg/m2 482 80.1 19.9
Maternal menarcheal age
,14 y 12,286 88.3 11.7
14–15 y 51,556 90.8 9.2
.15 y 24,275 92.3 7.7
Maternal education
,high school 66,928 91.5 8.5
High school 15,637 88.7 11.3
.high school 5813 88.9 11.1
Maternal occupation
Farm work/housework 59,539 91.6 8.4
Routine job 23,134 89.7 10.3
Others 5703 88.1 11.9
Maternal parity
Primiparous 72,959 90.4 9.6
Multiparous 15,491 93.1 6.9
Cesarean delivery
No 23,758 92.8 7.2
Yes 64,432 90.1 9.2
Offspring sex
Boy 45,654 89.9 10.1
Girl 42,763 91.9 8.1
High BP in first trimester
No 74,175 90.9 9.1
Yes 506 87.4 12.6
High BP in second trimester
No 85,601 90.9 9.1
Yes 704 83.2 16.8
High BP in third trimester
No 80,179 91.1 8.9
Yes 7818 89.0 11.0
Gestational wk 88,273 39.3 (1.12) 39.2 (1.10)
BP (mm Hg)
DBP in first trimester 74,683 68.4 (7.2) 68.9 (7.4)
SBP in first trimester 74,710 105.8 (10) 106.6 (10.3)
DBP in second trimester 86,320 69.0 (7.1) 69.6 (7.4)
SBP in second trimester 86,323 108.6 (10) 109.9 (10.4)
DBP in third trimester 87,993 75.2 (8.6) 76.0 (9.0)
SBP in third trimester 88,002 115.1 (11.4) 116.5 (11.6)
Infant birthweight (g) 88,312 3328.9 (400.6) 3443 (423.8)
High BP was defined as SBP $ 140 mm Hg or DBP $ 90 mm Hg.
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from the second to the third trimesters were positively
associated with risk for offspring overweight/obesity, but
surprisingly, no association was seen with BP change from
the first to the second trimester. In sensitivity analyses,
results were similar in the larger sample that included
hypertensive women (Supplemental Fig. 3).
Potential mediation by birthweight
Among normotensive women, in adjustedmodels, first-
trimester DBP and SBP were inversely associated with
birthweight. By contrast, second- and third-trimester
SBP (Supplemental Fig. 4) and change in SBP between the
first and third trimesters were positively associated with
birthweight (Supplemental Fig. 5). Conversely, maternal
hypertension at each of the three trimesters was associated
with lower birthweight (Supplemental Fig. 6).
Across both normotensive and hypertensive women,
the associations between second- and third-trimester
DBP and SBP and offspring birthweight were nonlinear
(Supplemental Fig. 7). In mediation analyses among
normotensive women, birthweight explained 24.2%,
9.2%, and 5.9% of the associations between second-
trimester SBP, third-trimester SBP, and change in SBP
from first to third trimesters with risk for offspring
overweight/obesity, respectively (Supplemental Table 2).
Discussion
In this large prospective cohort study,we found that higher
second- and third-trimester (but not first-trimester) DBP
and SBP among normotensive women were positively
associated with risk for offspring overweight/obesity. In
addition, changes in DBP and SBP between the first and the
third trimesters were positively associated with risk for
offspring overweight/obesity among normotensive women.
These associations were independent of maternal body size
and were only partially mediated by higher offspring
birthweight. Maternal hypertension in the second and third
trimesters (but not the first trimester) was also positively
associated with risk for offspring overweight/obesity yet
was associated with lower offspring birthweight.
To the best of our knowledge, only a few studies have
examined the prospective association of maternal hy-
pertensive status with risk for offspring overweight/
obesity (7, 8). In the Avon Longitudinal Study of Par-
ents and Children study in the United Kingdom, gesta-
tional hypertension, compared with normotension, was
Figure 1. ORs for offspring overweight/obesity per 10–mm Hg
increase in maternal BP at different pregnancy stages among
normotensive women. Logistic regression was performed, adjusting
for maternal characteristics (age, menarcheal age, education level,
occupation, parity status, corresponding DBP or SBP in the previous
trimesters), offspring sex, age at examination, maternal BMI, and
height.
Table 2. Association Between Maternal BP (per 10–mm Hg Increase) in Each Pregnancy Trimester Among
Normotensive Women With Risk for Offspring Overweight/Obesity at Age 4 to 7 Years
Pregnancy Stages/Model
DBP SBP
Participants (n) OR (95% CI) P Value Participants (n) OR (95% CI) P Value
First trimester
Model 1 74,141 1.10 (1.06–1.14) ,0.001 74,141 1.07 (1.05–1.10) ,0.001
Model 2 73,754 1.12 (1.08–1.16) ,0.001 73,754 1.09 (1.06–1.12) ,0.001
Model 3 73,524 1.03 (0.99–1.07) 0.109 73,524 1.02 (1.00–1.05) 0.106
Second trimester
Model 1 85,559 1.11 (1.08–1.15) ,0.001 85,559 1.13 (1.10–1.16) ,0.001
Model 2 72,898 1.10 (1.06–1.14) ,0.001 72,923 1.12 (1.09–1.16) ,0.001
Model 3 72,675 1.05 (1.01–1.09) 0.02 72,699 1.08 (1.05–1.11) ,0.001
Third trimester
Model 1 80,142 1.11 (1.07–1.15) ,0.001 80,142 1.12 (1.10–1.15) ,0.001
Model 2 66,726 1.08 (1.04–1.13) ,0.001 66,746 1.08 (1.05–1.11) ,0.001
Model 3 66,520 1.05 (1.01–1.10) 0.011 66,539 1.06 (1.03–1.09) ,0.001
The analyses were based onwomenwithout hypertension at each corresponding trimester.Model 1: crudemodel without adjustment.Model 2: adjusted
for maternal characteristics (age, menarcheal age, education level, occupation, parity status, and corresponding DBP or SBP at previous trimesters),
offspring sex, and age at examination. Model 3: model 2 plus maternal BMI and height.
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associated with a 41% (OR, 1.41; 95% CI, 1.02 to 1.95)
higher relative risk for offspring obesity at age 9 years (7).
In addition, a recent meta-analysis and systematic review
suggested that hypertensive disorders of pregnancy were
associated with higher adult offspring BMI and risk for
overweight/obesity (8).
Results from our present study confirm those previous
reports (7, 8), and add evidence that maternal second-
and third-trimester BP are positively associated with risk
for offspring overweight/obesity in women without hy-
pertension. The apparent positive association of first-
trimester BP with childhood overweight/obesity was
explained by confounding due to larger maternal size. In
particular, change in BP during pregnancy, especially
between the second and third trimesters, was positively
associated with offspring adiposity risk. Taken together,
our findings suggest that monitoring and control of the
BP rise from middle to late pregnancy might be impor-
tant, not only for pregnancy outcomes but also for the
prevention of childhood obesity.
There is accumulating evidence that high maternal BP
or hypertensive disorders of pregnancy are associated
with offspring BP (7, 8, 19–21). Epidemiologic studies
unequivocally support the positive association between
body weight and BP and between obesity and hyper-
tension (22). It was hypothesized that adiposity is along
the causal pathway of maternal gestational hypertensive
disorders with high BP in offspring (7). This speculation
needs confirmation in future studies.
The potential effects of pregnancy hypertensive dis-
orders and normal range BP during pregnancy on higher
risk for offspring obesity may involve quite different
mechanisms. Hypertensive disorders of pregnancy are
well-known causes of intrauterine growth restriction (5,
23, 24), and DBP .90 mm Hg (a threshold commonly
used to define hypertensive disorders) is inversely asso-
ciated with birthweight (9). Higher third-trimester um-
bilical artery vascular resistance, a parameter reflecting
the placental dysfunction (25, 26), has been associated
with slower fetal growth and a smaller size at birth but
higher childhood BMI (27). The mechanism linking in-
trauterine growth restriction with later adiposity may in-
clude change in fetal adipose tissue morphology and
metabolism, altered pathway regulating appetite, and
modification of hormone and epigenome in fetus (28).
Therefore, we postulated that hypertensive disorders during
pregnancy may promote childhood overweight/obesity
through its effect on intrauterine growth restriction.
High birthweight is also a well-known risk factor for
of childhood obesity (29). Therefore, we postulated that
among normotensive women, higher birthweight might
mediate the positive association between maternal SBP
and childhood overweight/obesity. However, the re-
lationship between maternal BP and offspring birth-
weight is complex. Our findings that first-trimester BP
was inversely associated with birthweight are consistent
with a recent genetic Mendelian randomization study
indicating a causal fetal growth-restricting effect of ma-
ternal SBP (30). First-trimester BP may be more strongly
correlated with prepregnancy BP and common genetic
determinants of nonpregnancy BP thanmid-pregnancy to
late pregnancy BP. In contrast to first-trimester BP and
hypertensive disorders, normal range maternal BP during
mid-pregnancy to late pregnancy is associated not with
Figure 3. ORs for offspring overweight/obesity per 10–mm Hg
increase in maternal BP during pregnancy among normotensive
women. Logistic regression was performed, adjusting for maternal
characteristics (age, menarcheal age, education level, occupation,
parity status, corresponding DBP or SBP at previous trimesters and
change in DBP or SBP between the previous trimesters (only for the
outcome of change in BP between second and third trimesters),
offspring sex, age at examination, maternal BMI, and height.
Figure 2. Association between maternal hypertension (compared
with normotensive women) at each pregnancy trimester with risk
for offspring overweight/obesity. Logistic regression was performed,
adjusting for maternal characteristics (age, menarcheal age,
education level, occupation, parity status, corresponding
hypertensive status at the previous trimesters), offspring sex,
age at examination, maternal BMI, and height.
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intrauterine growth restriction but with higher offspring
birthweight. Our findings are supported by a previous
large study of 210,814 mother-infant pairs: Maternal
DBP after 34 weeks’ gestation (but not earlier in preg-
nancy) showed an inverted U-shaped relation with
birthweight and perinatal survival, with a maximum
birthweight at a DBP of ~80 mm Hg (9).
Themechanismbehind the positive association between
normal-range BP and higher birth weight is unclear. In
the absence of placental vasculature resistance, increas-
ing maternal BP may be advantageous for placental
blood flow and fetal growth. However, late pregnancy
DBP.80 mmHg appears to be disadvantageous for both
short- and long-termhealth outcomes.That previous study
did not have data on SBP (8). We found that second-
trimester SBP was positively associated with birthweight,
even at above-normal range SBP, and birthweight medi-
ated 24% of the effect of the second-trimester SBP on
childhood overweight/obesity in our analysis. These re-
sults suggested that higher maternal second-trimester
SBP affected risk for offspring overweight/obesity, partly
through increasing birthweight of the children.
The strengths of this study include its large sample size,
prospective design, and high follow-up rate. In addition,
the JBC study has repeated BP measurements at different
stages of pregnancy, and both maternal and offspring
demographic characteristics and lifestyle are well docu-
mented at each visit by trained nurses or doctors. Fur-
thermore, the results of the current study are robust, as
suggested by a variety of sensitivity analyses.
The study has several limitations. First, maternal BP data
are based on a single measurement at each visit. Second, we
were unable to distinguish between gestational hyperten-
sion and preeclampsia due to lack of information on urine
protein. However, our primary aim was to examine BP
among normotensivewomen,with pregnancy hypertension
as a secondary exposure. Third, the JBC study is based on a
single region in southeast China and may not necessarily be
more broadly representative, althoughmany of our findings
are consistent with those seen in other populations. Fourth,
we did not adjust for excess weight gain during pregnancy
due to the heterogeneity of gestational weeks for the weight
measurement among different participants. Fifth, both
birthweight and postnatal weight gain might potentially
mediate the association between maternal BP and offspring
obesity. However, because of limited availability of post-
natal weight data up to 4 years, the mediation analysis
focused only on birthweight. Finally, there may be other
potential confounders in this observational study.
In conclusion, among normotensive women, greater
gestational rises in DBP and SBP were associated with
higher risk for offspring childhood overweight/obesity.
This association was partially mediated by higher
offspring birthweight. These findings provide insights
into the biologic mechanisms linking to childhood obe-
sity. The 5% to 8% increment in the odds of childhood
overweight/obesity corresponding to the higher maternal
BP in the second or third trimester might have important
public health implications for the prevention of child-
hood obesity, given the increasing prevalence of child-
hood obesity in the past decades in China. These findings
also added to the rationale to monitor and limit the BP
rise in mid-pregnancy to late pregnancy.
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